Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

44.74
+5.6414.42%
Post-market: 44.60-0.1400-0.31%19:24 EDT
Volume:48.12K
Turnover:2.11M
Market Cap:272.85M
PE:-22.78
High:47.83
Open:38.09
Low:38.09
Close:39.10
Loading ...

Monopar Therapeutics Coverage Assumed by Piper Sandler at Overweight

Dow Jones
·
19 Mar

Monopar Therapeutics Appoints Quan Vu as New CFO

TIPRANKS
·
04 Mar

BRIEF-Monopar Therapeutics Inc Says On Feb 28, CFO Karthik Radhakrishnan’S Employment Terminated

Reuters
·
04 Mar

Monopar Therapeutics Inc Says on Feb 28, CFO Karthik Radhakrishnan’s Employment Terminated - SEC Filing

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Inc - Quan Vu Appointed as CFO Effective March 3, 2025

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Inc Says Karthik Radhakrishnan Will No Longer Serve as Co's CFO, Principal Financial Officer, or Principal Accounting Officer

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Appoints Lavina Talukdar to Board

TIPRANKS
·
25 Feb

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

PR Newswire
·
24 Jan

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright

TipRanks
·
23 Jan

Analysts Are Bullish on These Healthcare Stocks: Monopar Therapeutics Inc (MNPR), Nektar Therapeutics (NKTR)

TIPRANKS
·
22 Jan

Monopar Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
22 Jan

Monopar Therapeutics files to sell 882,761 shares of common stock for holders

TIPRANKS
·
16 Jan

Piper Sandler Initiates Monopar Therapeutics at Overweight With $72 Price Target

MT Newswires Live
·
10 Jan

Monopar Therapeutics initiated with an Overweight at Piper Sandler

TIPRANKS
·
10 Jan

Monopar Therapeutics: Strategic Advancements and Promising Potential Drive Buy Rating

TIPRANKS
·
10 Jan

Monopar Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $72

THOMSON REUTERS
·
10 Jan